Therapy of human immunodeficiency virus infections.
Although therapy is currently available for many of the infections and neoplastic complications of AIDS, there is no effective therapy for the underlying immunodeficiency state. The authors review various attempts at treatment to date, and conclude that a major decrease in HIV-associated morbidity will require a combined approach, making use of our knowledge of the epidemiology, as well as the molecular and cellular biology, of the virus.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000628:therapy; D000998:Antiviral Agents / Q000627:therapeutic use; D017245:Foscarnet; D006801:Humans; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D009838:Oligodeoxyribonucleotides / Q000627:therapeutic use; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use; D013498:Suramin / Q000627:therapeutic use; D013936:Thymidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D015215:Zidovudine
D000998:Antiviral Agents; D009838:Oligodeoxyribonucleotides; D017245:Foscarnet; D012254:Ribavirin; D015215:Zidovudine; D013498:Suramin; D007372:Interferons; D010746:Phosphonoacetic Acid; D013936:Thymidine